-
Windlas Biotech lists at 5% discount to IPO price
The stock opened at Rs 437 on the National Stock Exchange (NSE) and at Rs 439 on the BSE.
-
Female participation rises in IPOs: Paytm Money
Devyani International saw the highest share of applications from Paytm Money investors under 25 years of age
-
Four new IPOs leave investors spoilt for choice; which one should you pick for your portfolio?
Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech are going to raise close to Rs 3,614 crore between August 4 and 6
-
Windlas Biotech IPO fully subscribed on Day 1
Half of the issue size has been reserved for QIBs, 35% for retail investors and the remaining 15% for non-institutional investors
-
Four IPOs open today: Check GMP and analysts view here
As many as six firms including Zomato, Rolex Rings and Tatva Chintan Pharma raised more than Rs 14,500 crore through public issues in July
-
Windlas Biotech IPO: Here’s what analysts are saying
The IPO comprises fresh issuance of equity shares worth Rs 165 crore and an offer for sale of up to 5,142,067 equity shares
-
Four IPOs to hit primary market on Aug 4; check GMP here
The largest franchisee of Pizza Hut, KFC and Costa Coffee in India has fixed a price band of Rs 86-90 a share for its Rs 1,838-crore IPO
-
18 IPOs likely to hit stock market in August
Euphoria in the primary markets is likely to continue in August as well and the number of IPOs both in value and volume can surpass July’s tally
-
Four IPOs to hit markets next week; key things to know
The three-day IPOs of Windlas Biotech, Devyani International, Krsnaa Diagnostics and Exxaro Tiles will open for public subscription on August 4
-
Windlas Biotech IPO opens next week; here is all need you to know
The pharma company has fixed a price band of Rs 448-460 per share having a face value of Rs 5 per share. The 401.54 crore issue opens on August 4
